Serum immunoglobulin E level in children with nephrotic syndrome


  • Shatha H. Ali Department of Pediatrics, College of Medicine, Al-Nahrain University, Kadhimiya, P.O. Box 70074, Baghdad, Iraq
  • Sabah H. Al-Shawi Al-Imamain Al-Kadhimain Medical City, Iraqi Ministry of Health, Kadhimiya, Iraq
  • Layla Q. Hiris Child Central Teaching Hospital, Iraqi Ministry of Health, Baghdad, Iraq



atopy, children, IgE, nephrotic syndrome, relapse


Background and objective: The most supported theory for Nephrotic Syndrome (NS) etiology is that it is immune-mediated. This study aims to assess the level of serum IgE in children with Steroid Sensitive NS (SSNS) at relapse and remission, and its correlation with the presence of atopy.

Methods: This cross-sectional study was approved by the Department of Pediatrics, College of Medicine, Al-Nahrain University (Baghdad, Iraq) and conducted at Al-Imamain Al-Kadhimain Medical City (Baghdad, Iraq), and Child Central Teaching Hospital (Baghdad, Iraq), and included 31 children SSNS. The data collected was: age, sex, residency, onset of NS, response to steroid, frequency of relapses, and the history of atopy of the patient and his relatives. Serum IgE level was measured during relapse for all patients and for 9 patients while in remission.

Results: Atopy was present in 18 (58.06%) of patients. The median serum IgE level was 295.5 IU/mL (range 54-2864 IU/mL) in relapse, which is significantly higher (P-value =0.006) than in remission 228.5 IU/mL (range 62-2069 IU/mL). Median serum level of IgE in patients with atopy was 290.5 IU/mL (range 24-2864 IU/mL) which was higher than that of patients without atopy (median 231 IU/mL, range 23-1314 IU/m) (P-value = 0.029). Patients required longer period to respond to steroid therapy (>10 days) had a significantly higher median of IgE (341 IU/mL) than those who required <10 days to respond (161 IU/mL) (P-value =0.045).

Conclusions: Increased IgE level is documented during relapse and in atopic children with SSNS. Longer duration to respond to steroid therapy is associated significantly with higher serum IgE during relapse.


Download data is not yet available.


A M Schijvens, L Van Der Weerd, and Jae Van Wijk. “Practice variations in the management of childhood nephrotic syndrome in the Netherlands”. Eur J Pediatr 180(6) (2021), pp. 1885–1894. DOI: 10.1007/s00431-021-03958-8. DOI:

Ahmed Abdul-Hassan Abbas et al. “Immunoglobulin E, Interleukin-17A and Transforming Growth Factor-β1 Levels in Children with Nephrotic Syndrome”. Int J Curr Microbiol App Sci 5(6) (2013), pp. 908–915. DOI: 10.20546/ijcmas.2016.506.098. DOI:

Ammar Basim Al-Assadi, Nidhal A. Mohammed, and Shatha H. Ali. “Serum Interleukin 13 (IL-13) levels in Iraqi children with nephrotic syndrome”. Int J Adv Res 6(10) (2018), pp. 385–388. DOI:

B A Vogt and E D Avner. “Condition particularly associated with proteinuria”. In: Nelson Textbook of Paediatrics. Ed. by R M Kliegman et al. Philadelphia: Saunders, 2007, pp. 2190–2195.

B M Lane et al. “Genetics of Childhood Steroid Sensitive Nephrotic Syndrome: An Update”. Front Pediatr 7 (2019). DOI: 10.3389/fped.2019.00008. DOI:

D Yılmaz et al. “Evaluation of children with steroid-sensitive nephrotic syndrome in terms of allergies”. Ren Fail 37(3) (2015), pp. 387–391. DOI: 10.3109/0886022X.2014.996087. DOI:

J Floege and J Feehally. “Introduction to glomerular disease: clinical presentations”. In: Comprehensive Clinical Nephrology. Ed. by R J Johnson, J Feehally, and J Floege. Philadelphia, USA: Elsevier/Saunders, 2015, pp. 184–197.

K O Gudmundsson et al. “Increased expression of interleukin-13 but not interleukin-4 in CD4+ cells from patients with the hyper-IgE syndrome”. Clin Exp Immunol 129(3) (2002), pp. 532–537. DOI: 10.1046/j.1365-2249.2002.01870.x. DOI:

L B Bacharier and R S Geha. “Molecular mechanisms of IgE regulation”. J Allergy Clin Immunol 105(2) (2000). DOI: 10.1016/s0091-6749(00)90059-9. DOI:

M Abdel-Hafez et al. “Idiopathic nephrotic syndrome and atopy: is there a common link”. Am J Kidney Dis 54(5) (2009), pp. 945–953. DOI: 10.1053/j.ajkd.2009.03.019. DOI:

M E Salsano et al. “Atopy in childhood idiopathic nephrotic syndrome”. Acta Paediatr 96(4) (2007), pp. 561–566. DOI: 10.1111/j.1651-2227.2007.00154.x. DOI:

N Asmaningsih, W Poernomo, and M Noer. “Serum immunoglobulin E levels in children with idiopathic nephrotic syndrome”. Paediatrica Indonesiana 45(2) (2016), pp. 55–64. DOI: 10.14238/pi45.2.2005.55-9. DOI:

P Mishra et al. “Serum immunoglobulin E and interleukin-13 levels in children with idiopathic nephrotic syndrome”. J Trop Pediatr 60(6) (2014), pp. 467–471. DOI: 10.1093/tropej/fmu040. DOI:

P Niaudet and O Boyer. “Idiopathic nephrotic syndrome in children: clinical aspects”. In: Pediatric Nephrology. Ed. by E Avner et al. Berlin, Heidelberg: Springer, 2016, pp. 839–869. DOI:

R Gbadegesin and W E Smoyer. “Nephrotic syndrome”. In: Comprehensive Pediatric Nephrology. Philadelphia, PA: Elsevier, 2008, pp. 205–218. DOI:

S N Uwaezuoke. “Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis”. Ital J Pediatr 41 (2015), pp. 19–19. DOI: 10.1186/s13052-015-0123-9. DOI:

T Adedoyin and A Adeniyi. “Preventive nephrology - proposed options in childhood nephropathy”. Niger J Paediatr 28(2) (2001). DOI: 10.4314/njp.v28i2.12056. DOI:

T Korsgaard et al. “Childhood onset steroid-sensitive nephrotic syndrome continues into adulthood”. Pediatr Nephrol 34(4) (2019), pp. 641–648. DOI: 10.1007/s00467-018-4119-8. DOI:

W Cheung et al. “Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome”. Pediatr Nephrol 19(6) (2004), pp. 627–632. DOI: 10.1007/s00467-004-1438-8. DOI:

Y S Youn, H H Lim, and J H Lee. “The clinical characteristics of steroid responsive nephrotic syndrome of children according to the serum immunoglobulin E levels and cytokines”. Yonsei Med J 53(4) (2012), pp. 715–722. DOI: 10.3349/ymj.2012.53.4.715 DOI:

Y Tan et al. “Elevated levels of immunoglobulin E may indicate steroid resistance or relapse in adult primary nephrotic syndrome, especially in minimal change nephrotic syndrome”. J Int Med Res 39(6) (2011), pp. 2307–2313. DOI: 10.1177/147323001103900629. DOI:



How to Cite

Ali, S., Al-Shawi, S., & Hiris, . L. (2022). Serum immunoglobulin E level in children with nephrotic syndrome. Baghdad Journal of Biochemistry and Applied Biological Sciences, 3(01), 40–50.